Experimental knee injection aims to ease arthritis pain
Disease control
Completed
This early-stage study tested the safety of an experimental drug called CYT-108 for people with mild to moderate knee osteoarthritis. Nineteen participants received either the drug or a placebo injection directly into their knee joint twice over 12 weeks. Researchers monitored pa…
Phase: PHASE1 • Sponsor: Cytonics Corporation • Aim: Disease control
Last updated Apr 02, 2026 07:27 UTC